TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial.

por Brigitte Dreno, Mirjana Urosevic-Maiwald, Youn Kim, Joan Guitart, Madeleine Duvic, Olivier Dereure, Amir Khammari, Anne-Chantal Knol, Anna Derbij, Monika Lusky, Isabelle Didillon, Anne-Marie Santoni, Bruce Acres, Vincent Bataille, Marie-Pierre Chenard, Pascal Bleuzen, Jean-Marc Limacher, Reinhard Dummer
Publicado 2014-01-01